Clinical and Radiological Profiles, Treatment, and Outcome of Pediatric Acquired Demyelinating Disorders of Central Nervous System

被引:5
作者
Gowda, Vykuntaraju K. [1 ]
Shetty, Deepthi [2 ]
Madivala, Bhaskar, V [3 ]
Benakappa, Naveen [2 ]
Benakappa, Asha [2 ]
机构
[1] Indira Gandhi Inst Child Hlth, Dept Pediat Neurol, Bengaluru, Karnataka, India
[2] Indira Gandhi Inst Child Hlth, Dept Pediat, Bengaluru, Karnataka, India
[3] Sparsh Super Special Hosp, Radiol, Bengaluru, Karnataka, India
关键词
ADEM; demyelinating disorders; multiple sclerosis; neuromyelitis optica; optic neuritis; transverse myelitis; ACUTE DISSEMINATED ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; CHILDREN;
D O I
10.4103/jpn.JPN_62_18
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Demyelinating disorders of central nervous system are rare childhood disorders that cause significant physical and cognitive disabilities. Early diagnosis and appropriate treatment determines prognosis and outcome. Objective: The objective of this work was to study clinical profile, investigative and radiological features, treatment, and outcome of children with demyelinating disorders. Materials and Methods: A retrospective chart review of 32 children with demyelinating disorders admitted in a tertiary-care pediatric hospital from Bangalore between November 2013 and October 2017 was conducted. Sociodemographic data, clinical features, cerebrospinal fluid (CSF) findings, radiological features, treatment received, and outcome were collected and results were analyzed. Results: Among 32 patients of demyelinating disorders, majority were acute disseminated encephalomyelitis (ADEM) (15, 46.9%), followed by transverse myelitis (9, 28.1%), multiple sclerosis (MS) (3, 9.4%), optic neuritis (3, 9.4%), and neuromyelitis optica (NMO) (2, 6.2%). Mean age of presentation was 7.8 years. Among 32 patients, 15 were male (47%). In patients with ADEM, the mean age of presentation was 5.5 years. Two patients had tumefactive ADEM and 10 recovered after steroid therapy. In patients with MS, the mean age of presentation was 10.6 years; one patient died and the condition of two patients improved. In patients with transverse myelitis, the mean age of presentation was 8.9 years and seven patients recovered. In a patient with NMO, CSF was positive for antibody to aquaporin-4. The child improved with steroids and intravenous immunoglobulin. Three patients with optic neuritis were treated with steroids and they recovered. Conclusion: Even though demyelinating disorders are rare in pediatric age group, one should be aware of this entity as early diagnosis and treatment improves outcome. Most common among them is ADEM.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 12 条
  • [1] Paediatric UK demyelinating disease longitudinal study (PUDDLS)
    Absoud, Michael
    Cummins, Carole
    Chong, Wui K.
    De Goede, Christian
    Foster, Katharine
    Gunny, Roxanna
    Hemingway, Cheryl
    Jardine, Philip
    Kneen, Rachel
    Likeman, Marcus
    Lim, Ming J.
    Pike, Mike
    Sibtain, Naomi
    Whitehouse, William P.
    Wassmer, Evangeline
    [J]. BMC PEDIATRICS, 2011, 11
  • [2] Multiple sclerosis and acute disseminated encephalomyelitis diagnosed in children after long-term follow-up: comparison of presenting features
    Alper, Gulay
    Heyman, Rock
    Wang, Li
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2009, 51 (06) : 480 - 486
  • [3] Anlar B, 2003, NEUROPEDIATRICS, V34, P194
  • [4] Dekate P S., 2014, Indian J Child Health, P128
  • [5] Fallah A, 2010, CAN J SURG, V53, P69
  • [6] Acquired demyelinating disorders of central nervous system: A pediatric cohort
    Gulati, Sheffali
    Chakrabarty, Biswaroop
    Kumar, Atin
    Jain, Puneet
    Patel, Harsh
    Saini, Lokesh
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2015, 18 : S48 - S55
  • [7] Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children
    Hynson, JL
    Kornberg, AJ
    Coleman, LT
    Shield, L
    Harvey, AS
    Kean, MJ
    [J]. NEUROLOGY, 2001, 56 (10) : 1308 - 1312
  • [8] Central nervous system inflammatory demyelinating disorders of childhood
    Kamate, Mahesh
    Chetal, Vivek
    Tonape, Venkatesh
    Mahantshetti, Niranjana
    Hattiholi, Virupaxi
    [J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2010, 13 (04) : 289 - 292
  • [9] International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
    Krupp, Lauren B.
    Tardieu, Marc
    Amato, Maria Pia
    Banwell, Brenda
    Chitnis, Tanuja
    Dale, Russell C.
    Ghezzi, Angelo
    Hintzen, Rogier
    Kornberg, Andrew
    Pohl, Daniela
    Rostasy, Kevin
    Tenembaum, Silvia
    Wassmer, Evangeline
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1261 - 1267
  • [10] CNS aquaporin-4 autoimmunity in children
    McKeon, A.
    Lennon, V. A.
    Lotze, T.
    Tenenbaum, S.
    Ness, J. M.
    Rensel, M.
    Kuntz, N. L.
    Fryer, J. P.
    Homburger, H.
    Hunter, J.
    Weinshenker, B. G.
    Krecke, K.
    Lucchinetti, C. F.
    Pittock, S. J.
    [J]. NEUROLOGY, 2008, 71 (02) : 93 - 100